Investors Urged to Join Class Action Against uniQure N.V. for Securities Fraud

Investors Urged to Join Class Action Against uniQure N.V.

The Schall Law Firm, a prominent U.S. litigation firm focused on shareholder rights, is actively reminding investors about the class action lawsuit against uniQure N.V. (NASDAQ: QURE). Shareholders who acquired the company’s securities between September 24, 2025, and October 31, 2025, are especially encouraged to get in touch with the firm and participate in the suit before the approaching deadline of April 13, 2026.

This class action targets alleged violations by uniQure under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, along with Rule 10b-5 as enforced by the U.S. Securities and Exchange Commission. The lawsuit states that uniQure made several misleading statements regarding its processes and the prospects of receiving full FDA approval for its ongoing Pivotal Study. These misrepresentations led to considerable confusion in the market about the company’s BLA submission timeline, ultimately affecting investors negatively when the truth surfaced.

Holding the company accountable is crucial for those who have experienced financial damages due to these misleading claims. The lawsuit asserts that uniQure did not adequately secure the necessary FDA approval, leaving its investors in a precarious position. When the realities of the company's exaggerated assurances were disclosed, it resulted in significant losses for shareholders.

Brian Schall, the founder of the Schall Law Firm, is available for free consultations regarding this severe issue. With a commitment to defending investors' rights, Schall specializes in securities class action lawsuits, providing support for those who found themselves misled.

Particularly poignant is the fact that the class in this case has yet to be certified by the court. Consequently, if investors do not take affirmation to engage, they will remain unrepresented as absent class members. The repercussions of staying out of the proceedings could mean missing out on potential recovery of losses caused by these fraudulent actions.

This lawsuit signifies a vital opportunity for affected investors to unite. The Schall Law Firm’s stellar reputation in representing clients around the globe gives campaign participants hope for recovering their losses. From small individual investors to institutional shareholders, everyone is encouraged to evaluate their positions and act before the legal window closes.

Additionally, the Schall Law Firm emphasizes that this communication can be classified as Attorney Advertising in certain jurisdictions, adhering to the legal standards of ethics. For those interested in more information, or looking to discuss their case with experienced legal professionals, reaching out via the firm's dedicated website or through the firm's office in Los Angeles is encouraged.

In summary, if you are a shareholder of uniQure N.V. and suffered during the specified time frame due to misleading information, now is the time to take action. Connecting with the Schall Law Firm could be a pivotal step towards recouping your financial losses. Don't miss out on this chance to be part of history as investors rally together against corporate malfeasance.